Alexion Announces Settlement On Eculizumab Patent; $66.4 Million In Sales For Soliris
This article was originally published in The Pink Sheet Daily
Executive Summary
The single-product company will pay Oklahoma Medical Research Foundation $10 million, ending a patent-infringement suit.